Clinical Trial Update: Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating linezolid, aspirin, and enhanced-dose rifampicin for HIV-associated tuberculous meningitis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis Meningitis

Drugs mentioned

• Aspirin (Aspirin)
• Linezolid (Linezolid)
• Rifampicin

Snippet

Sponsor: University of Cape Town | Conditions: Tuberculosis Meningitis, HIV-1-infection | Phase 2 | Status: COMPLETED